RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xenon Pharmaceuticals Stock

Xenon Pharmaceuticals P/E 2025

Xenon Pharmaceuticals P/E

-9.59

Ticker

XENE

ISIN

CA98420N1050

WKN

A12ETN

As of Jan 16, 2025, Xenon Pharmaceuticals's P/E ratio was -9.59, a -10.46% change from the -10.71 P/E ratio recorded in the previous year.

The Xenon Pharmaceuticals P/E history

Xenon Pharmaceuticals Aktienanalyse

What does Xenon Pharmaceuticals do?

Xenon Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of innovative therapies for rare diseases. It was founded in 1996 and is headquartered in Burnaby, British Columbia, Canada, with additional offices in the United States and Europe. The company has become a leading biotech company in the industry and focuses on identifying and developing treatments for rare diseases through its proprietary platform called Extreme Genetics. Xenon Pharmaceuticals has a wide pipeline of clinical candidates targeting diseases such as ichthyosis, X-linked adrenoleukodystrophy, pain disorders, and epilepsy. It collaborates with pharmaceutical companies to utilize its platform technology and expertise in the research of rare diseases. Its key drug candidate is XEN496 for the treatment of epilepsy. Overall, Xenon Pharmaceuticals plays a significant role in the biotech industry and continues to make progress in developing innovative therapies for rare diseases. Xenon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Xenon Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of Xenon Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Xenon Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Xenon Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Xenon Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Xenon Pharmaceuticals stock

What is the price-to-earnings ratio of Xenon Pharmaceuticals?

The price-earnings ratio of Xenon Pharmaceuticals is currently -9.59.

How has the price-earnings ratio of Xenon Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Xenon Pharmaceuticals has increased by -10.46% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Xenon Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Xenon Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Xenon Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Xenon Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Xenon Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Xenon Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Xenon Pharmaceuticals?

Some factors that influence the price-earnings ratio of Xenon Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Xenon Pharmaceuticals pay?

Over the past 12 months, Xenon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xenon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Xenon Pharmaceuticals?

The current dividend yield of Xenon Pharmaceuticals is .

When does Xenon Pharmaceuticals pay dividends?

Xenon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xenon Pharmaceuticals?

Xenon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Xenon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xenon Pharmaceuticals located?

Xenon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xenon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xenon Pharmaceuticals from 1/16/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/16/2025.

When did Xenon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 1/16/2025.

What was the dividend of Xenon Pharmaceuticals in the year 2024?

In the year 2024, Xenon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Xenon Pharmaceuticals pay out the dividend?

The dividends of Xenon Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Xenon Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Xenon Pharmaceuticals

Our stock analysis for Xenon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xenon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.